MGC Pharmaceuticals, Ltd.

mgcpharma.com.au

MGC Pharmaceuticals Ltd. is an Australian Company publicly listed on the ASX (ASX:MXC) founded in early 2015 by leading Israeli medical cannabis industry executives. The goal was establishing a global cannabinoid (CBD) and medical cannabis business utilizing their intellectual property, expertise and contacts, with a focus on the CBD market in Europe and Australia. MGC is operates globally with an agenda of adding value to the whole product chain, from growing and breeding unique strains to developing medicine delivery systems. With the Medical Cannabis industry, and particularly the CBD subsection of this industry booming globally, now is a time where making correct choices in partnerships and associations becomes most crucial.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

NANOPASS AND M2N ENTER STRATEGIC DEVELOPMENT & FOUNDRY AGREEMENT

NanoPass; M2N | December 23, 2021

news image

NanoPass Technologies and Micro2Nano have reached an agreement to enter a strategic development and production relationship for the design and production of NanoPass's proprietary MEMS based microneedles. The aim of the collaboration is to strengthen the relationship between NanoPass and M2N and provide a basis for the continued growth of the two comaim of the collaboration is to strengthen the relationship between NanoPass and M2N panies while basing the new agreement on year...

Read More

Pharma Tech

LEO PHARMA AND VEEVA SYSTEMS PARTNER FOR DIGITAL PATIENT-CENTERED TRIALS

LEO Pharma | September 30, 2021

news image

LEO Pharma , a global leader in medical dermatology, and Veeva Systems announced a strategic technology partnership to enable scalable digital trials, paperless and patient-centered. Building on its success with the Veeva Clinical Operations suite, LEO Pharma will complete its standardization on existing Veeva clinical technology, be an early adopter of future Veeva solutions, and help shape the Veeva digital trials roadmap. By adopting technology and optimized business processes,...

Read More

Business Insights

DAEWOONG PHARMACEUTICAL AND HANALL BIOPHARMA INVEST IN TURN BIOTECHNOLOGIES TO EXPAND GROWTH INITIATIVE

Daewoong Pharmaceutical and HanAll Biopharma | April 12, 2022

news image

Daewoong Pharmaceutical and HanAll Biopharma announced expansion of their open collaboration strategy by investing in Turn Biotechnologies, a Silicon Valley based company focused on developing novel mRNA medicines. The companies are supporting Turn Bio's continued development of a high-potential platform and are considering future long-term collaborations. Turn Bio is a pre-clinical-stage biopharmaceutical company focused on cellular repair via epigenetic reprogramming of cell...

Read More

Business Insights

EVEREST MEDICINES APPOINTS ROGERS YONGQING LUO AS CHIEF EXECUTIVE OFFICER TO LEAD NEXT STAGE OF COMPANY GROWTH

Everest Medicines | September 19, 2022

news image

Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets, announced that it has appointed Rogers Yongqing Luo as Chief Executive Officer of the Company, effective immediately. Mr. Luo will also serve as an Executive Director on Everest's Board of Directors. Mr. Luo brings to Everest more than 25 years of experience in the healthcare industry with an ext...

Read More
news image

Business Insights

NANOPASS AND M2N ENTER STRATEGIC DEVELOPMENT & FOUNDRY AGREEMENT

NanoPass; M2N | December 23, 2021

NanoPass Technologies and Micro2Nano have reached an agreement to enter a strategic development and production relationship for the design and production of NanoPass's proprietary MEMS based microneedles. The aim of the collaboration is to strengthen the relationship between NanoPass and M2N and provide a basis for the continued growth of the two comaim of the collaboration is to strengthen the relationship between NanoPass and M2N panies while basing the new agreement on year...

Read More
news image

Pharma Tech

LEO PHARMA AND VEEVA SYSTEMS PARTNER FOR DIGITAL PATIENT-CENTERED TRIALS

LEO Pharma | September 30, 2021

LEO Pharma , a global leader in medical dermatology, and Veeva Systems announced a strategic technology partnership to enable scalable digital trials, paperless and patient-centered. Building on its success with the Veeva Clinical Operations suite, LEO Pharma will complete its standardization on existing Veeva clinical technology, be an early adopter of future Veeva solutions, and help shape the Veeva digital trials roadmap. By adopting technology and optimized business processes,...

Read More
news image

Business Insights

DAEWOONG PHARMACEUTICAL AND HANALL BIOPHARMA INVEST IN TURN BIOTECHNOLOGIES TO EXPAND GROWTH INITIATIVE

Daewoong Pharmaceutical and HanAll Biopharma | April 12, 2022

Daewoong Pharmaceutical and HanAll Biopharma announced expansion of their open collaboration strategy by investing in Turn Biotechnologies, a Silicon Valley based company focused on developing novel mRNA medicines. The companies are supporting Turn Bio's continued development of a high-potential platform and are considering future long-term collaborations. Turn Bio is a pre-clinical-stage biopharmaceutical company focused on cellular repair via epigenetic reprogramming of cell...

Read More
news image

Business Insights

EVEREST MEDICINES APPOINTS ROGERS YONGQING LUO AS CHIEF EXECUTIVE OFFICER TO LEAD NEXT STAGE OF COMPANY GROWTH

Everest Medicines | September 19, 2022

Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets, announced that it has appointed Rogers Yongqing Luo as Chief Executive Officer of the Company, effective immediately. Mr. Luo will also serve as an Executive Director on Everest's Board of Directors. Mr. Luo brings to Everest more than 25 years of experience in the healthcare industry with an ext...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us